(Q34028612)

30 July 2017

1 reference

title

The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure (English)

1 reference

30 July 2017

1 reference

congestive heart failure

1 reference

A Hameedi

1

1 reference

30 July 2017

H L Chadow

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Current Hypertension Reports

30 July 2017

published in

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

378-383

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

30 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-000-0041-Z

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-000-0041-Z

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-000-0041-Z

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

12 December 2020

Essential hypertension: renin and aldosterone, heart attack and stroke.

1 reference

12 December 2020

Production of aldosterone in isolated rat blood vessels

1 reference

12 December 2020

Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro

1 reference

12 December 2020

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

1 reference

12 December 2020

Beta-adrenergic blocker mortality trials in congestive heart failure.

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Efficacy and tolerance of spironolactone in essential hypertension.

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Diuretic therapy for hypertension and the risk of primary cardiac arrest

1 reference

12 December 2020

The effects of chronic hepatic venous congestion on the metabolism of d,1-aldosterone and d-aldosterone

1 reference

12 December 2020

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

12 December 2020

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

12 December 2020

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

12 December 2020

High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes

1 reference

12 December 2020

PAI-1, obesity, insulin resistance and risk of cardiovascular events

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

Increased aortic impedance precedes peripheral vasoconstriction at the early stage of ventricular failure in the paced canine model

1 reference

12 December 2020

Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension

1 reference

12 December 2020

SPLANCHNIC EXTRACTION AND CLEARANCE OF ALDOSTERONE IN SUBJECTS WITH MINIMAL AND MARKED CARDIAC DYSFUNCTION

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

1 reference

12 December 2020

High affinity aldosterone binding sites (type I receptors) in rat heart

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibition Does Not Suppress Plasma Angiotensin II Increase During Exercise in Humans

1 reference

12 December 2020

Collagen in the hypertrophied, pressure-overloaded myocardium

1 reference

12 December 2020

Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats

1 reference

12 December 2020

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction

1 reference

12 December 2020

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

1 reference

12 December 2020

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

1 reference

12 December 2020

Ectopic arrhythmia provoking action of aldosterone

1 reference

12 December 2020

Arterial impedance as ventricular afterload

1 reference

12 December 2020

Rapid cardiovascular action of aldosterone in man.

1 reference

12 December 2020

Tissue angiotensin system in cardiovascular medicine. A paradigm shift?

1 reference

12 December 2020

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients

1 reference

12 December 2020

Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension

1 reference

12 December 2020

Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.

1 reference

12 December 2020

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

10.1007/S11906-000-0041-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1052965358

0 references

1 reference